Based on the Wall Street analyst consensus for 27 of LOGSX’s holdings.
LOGSX Analyst Price Target
Average Price Target
$30.22▲(6.33% Upside)
Based on Wall Street analyst 12-month price targets for 27 of Live Oak Health Sciences Fund’s holdings in the last 3 months. The average price target is $30.22 with a high forecast of $34.52 and a low forecast of $24.21. The average price target represents a 6.33% change from the last price of $28.42.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$34.52
Average$30.22
Low$24.21
Past 12 Months12 Month Forecast$21$24.5$28$31.5$35Feb2026May2026Aug2026Nov2026Nov2027
What is LOGSX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 27 of LOGSX’s holdings, Live Oak Health Sciences Fund’s 12-month average price target is $30.22.
What is LOGSX’s upside potential, based on the analysts’ average price target?
LOGSX’s average price target of $30.22 represents a 6.33% upside from its last price of $28.42.
Is LOGSX a Buy, Sell or Hold?
Live Oak Health Sciences Fund has a consensus rating of Moderate Buy, based on the analyst consensus for 27 of LOGSX’s holdings: 23 rated Buy, 4 rated Hold and 0 rated Sell.
What is Live Oak Health Sciences Fund’s price target?
The average price target for Live Oak Health Sciences Fund is $30.22, based on Wall Street analyst 12-month price targets for 27 of LOGSX’s holdings, issued in the past 3 months. The highest price target is $34.52 and the lowest is $24.21. The average price target represents a 6.33% increase from the last price of $28.42.
How can I buy shares of LOGSX?
You can buy shares of LOGSX through a brokerage account. Compare brokers on our Best Online Brokers page.